Thandeka Moyo to HIV Infections
This is a "connection" page, showing publications Thandeka Moyo has written about HIV Infections.
Connection Strength
0,761
-
HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 Viruses. AIDS Res Hum Retroviruses. 2020 12; 36(12):1010-1019.
Score: 0,198
-
Targeting the N332-supersite of the HIV-1 envelope for vaccine design. Expert Opin Ther Targets. 2020 06; 24(6):499-509.
Score: 0,192
-
Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11. J Virol. 2018 07 15; 92(14).
Score: 0,169
-
Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies. Virology. 2017 01 15; 501:12-24.
Score: 0,151
-
Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan. Sci Rep. 2018 10 09; 8(1):15031.
Score: 0,043
-
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. J Virol. 2015 May; 89(10):5264-75.
Score: 0,008